GLP-1 Focused Yazen Expands to Denmark with Acquisition of MedstartYazen's acquisition of Medstart enhances its obesity treatment solutions and market reach in Denmark and Norway, aiming to improve patient care across Europe.
America's doctors need more obesity medicine trainingThere is a shortage of healthcare providers trained in obesity care to meet the growing demand for weight-loss drugs.
Weight-loss drug restrictions shine spotlight on imbalance in obesity careRestrictions on weight-loss drugs raise concerns on coverage imbalanceEmployers offer limited coverage for obesity care compared to other conditions
America's doctors need more obesity medicine trainingThere is a shortage of healthcare providers trained in obesity care to meet the growing demand for weight-loss drugs.
Weight-loss drug restrictions shine spotlight on imbalance in obesity careRestrictions on weight-loss drugs raise concerns on coverage imbalanceEmployers offer limited coverage for obesity care compared to other conditions